295 related articles for article (PubMed ID: 37004324)
1. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases.
Rasouli-Saravani A; Jahankhani K; Moradi S; Gorgani M; Shafaghat Z; Mirsanei Z; Mehmandar A; Mirzaei R
Biomed Pharmacother; 2023 Jun; 162():114620. PubMed ID: 37004324
[TBL] [Abstract][Full Text] [Related]
2. Short chain fatty acids, a possible treatment option for autoimmune diseases.
Golpour F; Abbasi-Alaei M; Babaei F; Mirzababaei M; Parvardeh S; Mohammadi G; Nassiri-Asl M
Biomed Pharmacother; 2023 Jul; 163():114763. PubMed ID: 37105078
[TBL] [Abstract][Full Text] [Related]
3. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
5. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
6. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
7. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
Chen B; Sun L; Zhang X
J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
[TBL] [Abstract][Full Text] [Related]
8. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
9. Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases.
Belvoncikova P; Maronek M; Gardlik R
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142642
[TBL] [Abstract][Full Text] [Related]
10. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.
Yousefi B; Babaeizad A; Banihashemian SZ; Feyzabadi ZK; Dadashpour M; Pahlevan D; Ghaffari H; Eslami M
Curr Microbiol; 2022 Dec; 80(1):38. PubMed ID: 36527519
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CD4
Schiweck C; Edwin Thanarajah S; Aichholzer M; Matura S; Reif A; Vrieze E; Weigert A; Visekruna A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955407
[TBL] [Abstract][Full Text] [Related]
14. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases.
Zhang W; Mackay CR; Gershwin ME
J Immunol; 2023 Jun; 210(11):1629-1639. PubMed ID: 37186939
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
17. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
[TBL] [Abstract][Full Text] [Related]
18. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
[TBL] [Abstract][Full Text] [Related]
19. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
20. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
